Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir/Ritonavir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01772940
What this trial is testing

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Who this might be right for
HIV-1 Infection
Centre Hospitalier Universitaire Saint Pierre 425
Not applicableLooking for participantsNCT03603977
What this trial is testing

Simplified Treatment of Anti-retrovirus in China (C-STAR)

Who this might be right for
HIV/AIDS
Guangzhou 8th People's Hospital 600
Large-scale testing (Phase 3)Study completedNCT02227238
What this trial is testing

Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment

Who this might be right for
HIV Infections
ViiV Healthcare 627
Early research (Phase 1)UnknownNCT01259219
What this trial is testing

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Who this might be right for
Children With Confirmed HIV InfectionReceiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard DoseSuccessfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment
Harriet Shezi Children's Clinic 40
Not applicableStudy completedNCT01383005
What this trial is testing

Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

Who this might be right for
Human Immunodeficiency Virus Infection
AbbVie (prior sponsor, Abbott) 97
Large-scale testing (Phase 3)Study completedNCT00140751
What this trial is testing

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

Who this might be right for
HIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 186
Large-scale testing (Phase 3)Study completedNCT00358917
What this trial is testing

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

Who this might be right for
Human Immunodeficiency Virus Infections
Abbott 599
Testing effectiveness (Phase 2)Study completedNCT00046033
What this trial is testing

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Post-approval studies (Phase 4)Ended earlyNCT00632970
What this trial is testing

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Who this might be right for
HIV Infections
George Washington University 6
Post-approval studies (Phase 4)Study completedNCT00752037
What this trial is testing

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

Who this might be right for
HIV Infections
Saint Michael's Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00318123
What this trial is testing

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 126
Not applicableStudy completedNCT00762320
What this trial is testing

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Who this might be right for
HIV Infections
Phoenix Children's Hospital 8
Testing effectiveness (Phase 2)Study completedNCT00887120
What this trial is testing

Dose Reduction of Lopinavir in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 24
Not applicableStudy completedNCT00102986
What this trial is testing

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 116
Not applicableStudy completedNCT00179335
What this trial is testing

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Who this might be right for
HIV Infections
Albert Einstein College of Medicine 45
Post-approval studies (Phase 4)Study completedNCT00438152
What this trial is testing

Lopinavir Capsules to Kaletra or Invirase Tablets

Who this might be right for
HIV Infections
Royal Free Hampstead NHS Trust 53
Early research (Phase 1)Study completedNCT01148004
What this trial is testing

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Who this might be right for
HIVFenofibrateProtease Inhibitors+2 more
National Institutes of Health Clinical Center (CC) 25
Post-approval studies (Phase 4)Study completedNCT01533272
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Not applicableWithdrawnNCT00023218
What this trial is testing

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT01083810
What this trial is testing

Evaluation of Kaletra Therapy Over the Long-term

Who this might be right for
Human Immunodeficiency Virus
Abbott 284
Next Page